Showing 861-870 of 2027 results for "".
An Exciting Year in Dermatology
https://practicaldermatology.com/topics/psoriasis/an-exciting-year-in-dermatology/19929/From new topicals to novel systemic agents, several treatments may be coming to the market in the next two years, while existing therapies may see label expansions. Bruce Strober, MD, PhD offers a look at new MOAs and the evidence for their use.FDA Approves Roflumilast for Seborrheic Dermatitis in Young Patients
https://practicaldermatology.com/topics/other-dermatitis/fda-approves-roflumilast-for-seborrheic-dermatitis-in-young-patients/20230/Patrick Burnett, MD, PhD, chief medical officer of Arcutis Biotherapeutics, talks with Practical Dermatology® about the first new treatment for seborrheic dermatitis in more than 20 years, their newly approved ZORYVE (roflumilast)Topical Foam, 0.3% for use in patients aged 9 years or older.Of Sharks and Sunscreen
https://practicaldermatology.com/series/scientifically-speaking/of-sharks-and-sunscreen/20130/Often called on to judge "Shark Tank"-style competitions, Humberto Antunes has an eye for what makes an idea work. He talks with host Joel L. Cohen, MD about ingredients for success and also offers insight on sunscreen access in the US.Clinical Conversations: The Data for JAK Inhibitors in AD
https://practicaldermatology.com/series/jak-inhibitors-in-practice/clinical-conversations-the-data-for-jak-inhibitors-in-ad/20105/JAK inhibitors represent a new therapeutic class for the treatment of atopic dermatitis. Find out what the data show about their efficacy and tolerability in a conversation between Brad Glick, DO and Raj Chovatiya, MD. Discover how these drugs can fit into the treatment plan and how these experts diPrescribing Biologics: Don't Be Afraid
https://practicaldermatology.com/conferences/aad-summer-2021/prescribing-biologics-dont-be-afraid/19969/Dermatologists have access to a growing armamentarium of safe and effective systemic therapies, but many physicians and patients are still hesitant to use them. Neal Bhatia, MD discusses the importance of prescribing biologics to patients with moderate to severe psoriasis to offer a safe and efficacPower of the Group: Quality of Care in AD
https://practicaldermatology.com/topics/atopic-dermatitis/power-of-the-group-quality-of-care-in-ad/19880/When researchers undertook a survey of eczema centers worldwide, they uncovered common barriers to care and identified potential solutions. Eric Simpson, MD, MCR provides on overview of the Quality of Care in Atopic Dermatitis initiative, with an emphasis on the value of the group-based analysis ofToxin Time: What’s New and Exciting with Neuromodulators
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/toxin-time-whats-new-and-exciting-with-neuromodulators/19768/Joel Cohen, MD takes a deep dive into the most recent data on neuromodulators including post-hoc analyses on the potential durability of response. Dr. Cohen also shares updates on Revance’s DAXI, Botox Cosmetic and liquid toxins under development by Galderma and Allergan.Advances in Treating Pediatric Inflammatory Skin Diseases
https://practicaldermatology.com/topics/pediatric/advances-in-treating-pediatric-inflammatory-skin-diseases/19739/From new treatment guidelines to emerging biologic therapies for psoriasis in pediatric patients, Lawrence Eichenfield, MD says there’s new hope in successfully treating this patient population. He also discusses advances in treating pediatric atopic dermatitis.Introducing SDDS
https://practicaldermatology.com/topics/practice-management/introducing-sdds/19718/Jashin J. Wu, MD, Founder and Course Director, San Diego Dermatology Symposium, introduces a new meeting with topics in acne, psoriasis, pediatric dermatology, cutaneous oncology, and more. UPDATE: The inaugural 2020 San Diego Dermatology Symposium will be held September 11-13, 2020 at the InterConAdvancing Treatment Parameters in Skin of Color with PicoWay
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/advancing-treatment-parameters-in-skin-of-color-with-picoway/19623/Join William Kwan, MD for an overview of advanced treatment guidelines for addressing benign Pigmented Lesions with the PicoWay system. Learn how this picosecond laser has minimized risk relative to Q-switched lasers in the treatment of CALMs, lentigines, and more. New case studies from India and Ta